Why would hemp / cannabinoid products be classified as "new food" wrong?
In the UK, under pressure from GW Pharmaceuticals lobbyists, a decision was made at the level of regulatory acts to equate cannabidiol with pharmaceutical preparations. This put an end to the free sale of various products containing the above substance, as manufacturers must comply with the research standards governing each drug manufactured for free trade. For example, cannabidiol is included in the list of ingredients of European cosmetic products (CAS No. 13956-29-1) for its antioxidant, anti-isothermal, softening and protective effect has already been reclassified and can be found in cosmetic products subject to the restrictions imposed by the Single Convention on Narcotic Drugs. / strong>
On the pages of the profile electronic edition of Ukrainian growers in the article "The boom in sales of cannabinoid products in Austria is canceled" already described the mechanism used by officials in individual EU countries to lobby for the interests of specific manufacturers of pharmacological products.
At a time when cannabidiol (CBD) is widely known, starting with patients using this drug-free cannabiinoid to treat a number of diseases and ending with entrepreneurs, as well as farmers, the first attempts aimed at legislative restrictions of the above therapeutic substance can be observed at the international level.
At the end of 2018, the discussion about the attitude towards CBD at the level of the World Health Organization (WHO) ended. As a result, WHO recommended not to include this drug-free cannabinoid in the list of controlled substances. Moreover, the decision was confirmed that cannabis should be reclassified internationally, stating separately that cannabidiol-based preparations and CBD concentrates containing not more than 0.2% tetrahydrocannabinol should not be under international control.
On the other hand, “European Union” officials decided to include cannabis flowers, cannabidiol and cannabinoids in general (including extracts) in the list of so-called “new products”. These are goods that require a lengthy and significantly more expensive authorization process in order to be given the opportunity to enter the market as a "new product". In particular, despite the fact that various historical sources specifically indicate that cannabis has been used for several hundred years as a food product, as a cosmetic or medicinal product, European officials claim that there is not enough evidence on the tradition of eating cannabis until May 1997.
In connection with the non-constructive policies of EU officials, the European Industrial Cannabis Association (EIHA) officially states in the media that a tradition of using different parts of cannabis as a traditional food source has a few thousand years. Various evidence is provided, including excerpts from the oldest European and Asian treatises, which indicate the mechanisms, as well as recipes for the use of cannabis as a traditional agricultural product. EIHA representatives emphasize that the EU should adopt a strategy that will allow European cannabis companies to compete on the world stage, demonstrating the achievements of rapidly growing markets in Asian countries, the USA and Canada, as well as the approaches of government officials who strongly promote development as an industry. in general, and some of the most profitable sectors of modern hemp breeding.
An example is the Italian law on industrial cannabise (242/2016), which encourages and promotes the cultivation and processing of cannabis for food and cosmetic purposes. The fact that the mechanism of working with leaves and inflorescences of a plant is not directly indicated in the above legal act does not mean that "green mass" Cannabis can not be used. This is indicated by a recent clarification by the Supreme Court of Cassation of Italy (4920/2019).
Commentary of the Association "Ukrainian technical hemp"
In the UK, under pressure from lobbyists, GW Pharmaceuticals, at the level of regulatory acts, decided to equate cannabidiol with pharmaceutical preparations. This put an end to the free sale of various products containing the above substance, as manufacturers must comply with the research standards governing each drug manufactured for free trade. For example, cannabidiol is included in the list of ingredients of European cosmetic products (CAS No. 13956-29-1) for its antioxidant, anti-isothermal, softening and protective effect has already been reclassified and can be found in cosmetic products subject to the restrictions imposed by the Single Convention on Narcotic Drugs.